黄芪生脉饮佐治病毒性心肌炎的临床效果观察

TreatingViral Myocarditis with Huangqi Shengmai Yin

夏进  徐臻  

（广东省第二中医院，广东  广州，510095）

中图分类号：R256.2    文献标识码：A    文章编号：1674-7860(2015)27-0079-02    证型：IBGD

【摘  要】目的：分析和探讨黄芪生脉饮佐治病毒性心肌炎的临床效果。方法：选择从2012年12月—2014年12月在本院进行治疗的病毒性心肌炎患者70例，以35例为1组，分为观察组和对照组，对照组行常规治疗，在此基础上观察组行黄芪生脉饮佐治。观察并对比两组的治疗效果。结果：组内比较，收缩压治疗前后无显著变化（P＞0.05），心肌耗氧量、心率明显减低比较差异具有统计学意义（P＜0.05）；组间比较，两组收缩压无显著差异（P＞0.05），观察组心肌耗氧量、心率更低，比较差异具有统计学意义（P＜0.05）。观察组治疗有效34例，占97.1%，对照组治疗有效28例，占80.0%，有效率比较，观察组高于对照组，比较差异具有统计学意义（P＜0.05）。结论：在病毒性心肌炎的常规治疗中加用黄芪生脉饮，可改善患者的心肌功能，提升治疗效果，具有较高的应用价值。

【关键词】黄芪生脉饮佐治；病毒性心肌炎；临床效果

【Abstract】Objective: Toanalyze clinical efficacy of the Huangqi Shengmai Yin. Methods: 70 cases ofviral myocarditis were divided into two group,with 35 cases per group, theobservation group were given the Huangqi Shengmai Yin. Results: Within the group,no significant change at BP (P>0.05),before and after treatment systolic blood pressure, myocardial oxygenconsumption, heart rate was significantly lower and the difference wasstatistically significant (P<0.05);between the groups, no significant difference at systolic blood groups (P>0.05), in the observationmyocardial oxygen consumption and heart rate were lower, the difference wasstatistically significant (P<0.05).In the observation group 34 cases were effective, accounting for 97.14%; in thecontrol group 28 cases were effective, accounting for 80.00%, (P<0.05). Conclusion: The HuangqiShengmai Yin can improve cardiac function with a high value.

【Keywords】The HuangqiShengmai Yin; Viral myocarditis; Clinical effect

doi:10.3969/j.issn.1674-7860.2015.27.039

请点击此处【在线阅读全文PDF格式】

详情可登录【万方数据】

也可登录【中国知网】